FdaApplication
ANDA 211623
Identifiers
- fda_app_no: ANDA211623
Properties
| Property | Value |
|---|---|
| applicant_name | UNIQUE PHARMACEUTICAL LABORATORIES |
| application_type | ANDA |
| approval_date | 2020-04-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBAMAZEPINE | CARBAMAZEPINE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| CARBAMAZEPINE | CARBAMAZEPINE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
| CARBAMAZEPINE | CARBAMAZEPINE | 400MG | TABLET, EXTENDED RELEASE;ORAL |
3 products